Background

Historically, the wide range of symptoms associated with fibromyalgia and the lack of a definitive diagnostic test have made it hard to identify the disease. Doctors needed to eliminate other possibilities before diagnosing fibromyalgia, a process that can take years to complete and cost tens of thousands of dollars. Not surprisingly, an estimated three out of four people with fibromyalgia remain undiagnosed today. The FM/a® Test is changing all that.

The patented FM/a® Test, owned by EpicGenetics, Inc., is the first and currently the only definitive blood test to objectively diagnose fibromyalgia. It is the result of award-winning research and independent clinical studies performed at the University of Illinois College of Medicine.

Since 2013, the FM/a® fibromyalgia blood test has successfully diagnosed thousands of patients and has a 99% accuracy rate.

The FM/a® Test was developed under the leadership of Bruce S. Gillis, M.D., M.P.H. Dr. Gillis has held faculty positions both at the University of California, Los Angeles and the University of Illinois College of Medicine at Chicago. For the past several years he has maintained active research programs at multiple university medical centers.

The patented FM/a® Test, owned by EpicGenetics, Inc., is the first and currently the only definitive blood test to objectively diagnose fibromyalgia. It is the result of award-winning research and independent clinical studies performed at the University of Illinois College of Medicine.

Since 2013, the FM/a® fibromyalgia blood test has successfully diagnosed thousands of patients and has a 99% accuracy rate.

The FM/a® Test was developed under the leadership of Bruce S. Gillis, M.D., M.P.H. Dr. Gillis has held faculty positions both at the University of California, Los Angeles and the University of Illinois College of Medicine at Chicago. For the past several years he has maintained active research programs at multiple university medical centers.

2012

The FM/a® Test is first offered to the public. The findings of Professor Behm’s team leads the ...
Read more

2013

The FM/a® Test gains CLIA and CAP certification....
Read more

2014

The test is licensed in 49 states....
Read more

2016

The FM/a® Test gains approval for Medicare coverage and begins accepting insurance....
Read more

2017

Research begins on a Genomics study at The University of Illinois College of Medicine at Chicago. ...
Read more

2019

EpicGenetics moves from 3,716 sq. foot facility to new 11,800 square foot facility....
Read more

2020

EpicGenetics continues to grow, processing more than 30,000 patient test appliciations and collabora...
Read more